These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 27036031)
1. Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes. Dong W; Ding T; Wu L; Ren X; Epling-Burnette PK; Yang L Oncotarget; 2016 May; 7(19):27479-88. PubMed ID: 27036031 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes. Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes. Deshet-Unger N; Oster HS; Prutchi-Sagiv S; Maaravi N; Golishevski N; Neumann D; Mittelman M Leuk Res; 2017 Jan; 52():20-27. PubMed ID: 27870945 [TBL] [Abstract][Full Text] [Related]
4. Peripheral human CD4 Clénet ML; Gagnon F; Moratalla AC; Viel EC; Arbour N Sci Rep; 2017 Sep; 7(1):11612. PubMed ID: 28912605 [TBL] [Abstract][Full Text] [Related]
5. Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome. Zou JX; Rollison DE; Boulware D; Chen DT; Sloand EM; Pfannes LV; Goronzy JJ; Bai F; Painter JS; Wei S; Cosgrove D; List AF; Epling-Burnette PK Leukemia; 2009 Jul; 23(7):1288-96. PubMed ID: 19282834 [TBL] [Abstract][Full Text] [Related]
7. Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells. Li J; Yue L; Wang H; Liu C; Liu H; Tao J; Qi W; Wang Y; Zhang W; Fu R; Shao Z J Immunol Res; 2016; 2016():9404705. PubMed ID: 27722177 [TBL] [Abstract][Full Text] [Related]
8. Effect of IL-7 Therapy on Naive and Memory T Cell Homeostasis in Aged Rhesus Macaques. Okoye AA; Rohankhedkar M; Konfe AL; Abana CO; Reyes MD; Clock JA; Duell DM; Sylwester AW; Sammader P; Legasse AW; Park BS; Axthelm MK; Nikolich-Žugich J; Picker LJ J Immunol; 2015 Nov; 195(9):4292-305. PubMed ID: 26416281 [TBL] [Abstract][Full Text] [Related]
9. Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome. Iwase O; Aizawa S; Kuriyama Y; Yaguchi M; Nakano M; Toyama K Ann Hematol; 1995 Dec; 71(6):293-9. PubMed ID: 8534761 [TBL] [Abstract][Full Text] [Related]
10. Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals. Rajamanickam A; Pavan Kumar N; Pandiaraj AN; Selvaraj N; Munisankar S; Renji RM; Venkataramani V; Murhekar M; Thangaraj JWV; Muthusamy SK; Chethrapilly Purushothaman GK; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Babu S J Leukoc Biol; 2022 Jul; 112(1):201-212. PubMed ID: 35258122 [TBL] [Abstract][Full Text] [Related]
11. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes. Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248 [TBL] [Abstract][Full Text] [Related]
12. Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells. Herndler-Brandstetter D; Landgraf K; Jenewein B; Tzankov A; Brunauer R; Brunner S; Parson W; Kloss F; Gassner R; Lepperdinger G; Grubeck-Loebenstein B J Immunol; 2011 Jun; 186(12):6965-71. PubMed ID: 21562158 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the subsets of lymphocytes and their activated status in patients with myelodysplastic syndrome]. Yang J; Wang C; Xie KC; Yan SK; Gao YR; Cai Q; Qin YW; Wan LP; Cai Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):708-13. PubMed ID: 16928305 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. Melchionda F; Fry TJ; Milliron MJ; McKirdy MA; Tagaya Y; Mackall CL J Clin Invest; 2005 May; 115(5):1177-87. PubMed ID: 15841203 [TBL] [Abstract][Full Text] [Related]
15. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. Judge AD; Zhang X; Fujii H; Surh CD; Sprent J J Exp Med; 2002 Oct; 196(7):935-46. PubMed ID: 12370255 [TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic patterns of CD8+ T cell subsets expressing CD8alphaalpha and IL-7Ralpha in viremic, aviremic and slow progressor HIV-1-infected subjects. Boulassel MR; Mercier F; Gilmore N; Routy JP Clin Immunol; 2007 Aug; 124(2):149-57. PubMed ID: 17560832 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of T cell subsets and CD3zeta chain expression in myelodysplastic syndrome patients]. Xu F; Liu T; Zhu HL; Cui X; Xu CG; Mao YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):779-82. PubMed ID: 15631660 [TBL] [Abstract][Full Text] [Related]
19. [Levels and Significance of Serum Interleukin-35 and the New Regulatory T Cells -iTR35 Cells in Myelodysplastic Syndrome Patients]. Xu WQ; Huang YM; Xiao HF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):157-163. PubMed ID: 28245394 [TBL] [Abstract][Full Text] [Related]
20. IL-7 concentration is increased in nonagenarians but is not associated with markers of T cell immunosenescence. Marttila S; Jylhävä J; Pesu M; Hämäläinen S; Jylhä M; Hervonen A; Hurme M Exp Gerontol; 2011 Dec; 46(12):1000-2. PubMed ID: 21964236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]